Overview

Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder

Status:
Recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Botulax® in treatment of Overactive Bladder
Phase:
Phase 1
Details
Lead Sponsor:
Hugel
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A